Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.

Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR.

Am J Med. 2010 Jan;123(1):47-53. doi: 10.1016/j.amjmed.2009.05.032.

PMID:
20102991
2.

Proton-pump inhibitor use and the risk for community-acquired pneumonia.

Sarkar M, Hennessy S, Yang YX.

Ann Intern Med. 2008 Sep 16;149(6):391-8.

PMID:
18794558
3.

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J.

Arch Intern Med. 2007 May 14;167(9):950-5.

PMID:
17502537
4.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).

Pediatrics. 2006 May;117(5):e817-20.

PMID:
16651285
5.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

6.

Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV.

Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18.

PMID:
22100573
7.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
8.

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ.

Medicine (Baltimore). 2008 Nov;87(6):329-34. doi: 10.1097/MD.0b013e318190f444.

9.

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA.

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978.

10.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB.

JAMA. 2004 Oct 27;292(16):1955-60.

PMID:
15507580
11.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM.

CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.

12.

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K.

Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31.

PMID:
19337238
13.
14.

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S.

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

15.

Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.

Rahme E, Barkun A, Nedjar H, Gaugris S, Watson D.

Am J Gastroenterol. 2008 Apr;103(4):872-82. doi: 10.1111/j.1572-0241.2008.01811.x. Epub 2008 Mar 26.

PMID:
18371130
16.

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.

Johnstone J, Nerenberg K, Loeb M.

Aliment Pharmacol Ther. 2010 Jun;31(11):1165-77. doi: 10.1111/j.1365-2036.2010.04284.x. Epub 2010 Mar 4.

17.

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.

van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):880-90. doi: 10.1002/pds.1782.

PMID:
19593747
18.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
19.

Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.

Eurich DT, Lee C, Marrie TJ, Majumdar SR.

Clin Infect Dis. 2013 Oct;57(8):1138-44. doi: 10.1093/cid/cit472. Epub 2013 Jul 19.

PMID:
23872948
20.

Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.

Meijvis SC, Cornips MC, Voorn GP, Souverein PC, Endeman H, Biesma DH, Leufkens HG, van de Garde EM.

Eur Respir J. 2011 Nov;38(5):1165-72. doi: 10.1183/09031936.00020811. Epub 2011 Apr 8.

Supplemental Content

Support Center